Weak Q3 For Cipla
  • WebDesk BTVI
  • Feb 07 2019

Drug major Cipla on Wednesday reported a 20 per cent year-on-year dip in consolidated net profit to Rs 322.24 crore for the December 2018 quarter. The company's Managing Director and Global Chief Executive Officer Umang Vohra gives a breakdown of the Q3 numbers and the company's performance during the quarter.